•1 min read•from TechCrunch
FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder
Our take
In a recent episode of Build Mode, BioticsAI CEO Robhy Bustami shared insights into the challenges and triumphs of navigating the healthcare landscape. Discussing the intricacies of FDA approval, Bustami highlighted the importance of perseverance in a highly regulated environment. He emphasized the significance of maintaining team motivation while effectively addressing the complexities of fundraising. Bustami’s leadership approach not only cuts through red tape but also fosters a culture of innovation, positioning BioticsAI as a forward-thinking player in the healthcare technology sector.
BioticsAI CEO Robhy Bustami joined Isabelle Johannessen on Build Mode to discuss how the company has navigated a highly regulated space and kept the team motivated while cutting through all the red tape.
Read on the original site
Open the publisher's page for the full experience
Tagged with
#FDA approval#BioticsAI#healthcare#regulated space#fundraising#Robhy Bustami#navigating regulations#compliance#CEO#red tape#healthcare innovation#business development#Isabelle Johannessen#team motivation#entrepreneurship#startup culture#Build Mode#company strategy#venture capital#biotechnology